John Neoptolemos

Professor of Surgery

Heidelberg University

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Neoptolemos is a Professor of Surgery at the University of Heidelberg, Germany. His research primarily focuses on pancreatic cancer, with recent contributions addressing treatment modalities and outcomes in localized pancreatic conditions. He has published significant articles on topics such as neoadjuvant therapy and personalized treatment approaches in pancreatic adenocarcinoma.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Jörg Kleeff

GERMANY

View details

Niels Grabe

Professor for Data Analysis in Novel Clinical Diagnostics

Universitätsmedizin Göttingen

GERMANY

View details

Teresa Peccerella

University Hospital Heidelberg

GERMANY

View details

LUIGI RICCIARDIELLO

Professor

MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Neoptolemos

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Reply to: Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4

Letter re: Outcomes of percutaneous endoscopic versus endoscopic transmural necrosectomy for necrotizing pancreatitis

Letter to the Editor: The duodenum-preserving head resections for chronic pancreatitis: Beger, Livocado and Pottakkat

The duodenum-preserving head resection for chronic pancreatitis of Hans Günter Beger and subsequent modifications

Personalized treatment in localized pancreatic cancer

Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival

Interpreting Primary End Points in Randomized Trials of Pancreatic Cancer

Neoadjuvant therapy for pancreatic cancer

The NEONAX study

The role of neoadjuvant therapy for resectable pancreatic cancer remains uncertain

The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better

Severe acute pancreatitis: surgical indications and treatment

Impaired autophagy increases susceptibility to endotoxin-induced chronic pancreatitis

Pancreatic cancer incidence and survival and the role of specialist centres in resection rates in England, 2000 to 2014: A population-based study

Collaborators (4)

Jörg Kleeff

Niels Grabe

Teresa Peccerella

LUIGI RICCIARDIELLO

Make your next move.